Maja Ilic
Overview
Explore the profile of Maja Ilic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shipley J, Oester R, Mathieu-Resuge M, Parmar T, Kowarik C, Ilic M, et al.
Science
. 2024 Oct;
386(6719):335-340.
PMID: 39418379
Human land-use intensification threatens arthropod (for example, insect and spider) biodiversity across aquatic and terrestrial ecosystems. Insects and spiders play critical roles in ecosystems by accumulating and synthesizing organic nutrients...
2.
Laniece Delaunay C, Mazagatos C, Martinez-Baz I, Turi G, Goerlitz L, Domegan L, et al.
JAMA Netw Open
. 2024 Jul;
7(7):e2419258.
PMID: 38949812
Importance: In the context of emerging SARS-CoV-2 variants or lineages and new vaccines, it is key to accurately monitor COVID-19 vaccine effectiveness (CVE) to inform vaccination campaigns. Objective: To estimate...
3.
Maurel M, Mazagatos C, Goerlitz L, Oroszi B, Hooiveld M, Machado A, et al.
Vaccine
. 2024 May;
42(16):3547-3554.
PMID: 38704257
Background: Within influenza vaccine effectiveness (VE) studies at primary care level with a laboratory-confirmed outcome, clinical case definitions for recruitment of patients can vary. We used the 2022-23 VEBIS primary...
4.
Skelin M, Perkov-Stipicin B, Vuskovic S, Sandrk Plehacek M, Basic A, Sarcevic D, et al.
Oncol Res
. 2024 Apr;
32(5):807-815.
PMID: 38686053
Background: The European Society for Medical Oncology (ESMO) guidelines are among the most comprehensive and widely used clinical practice guidelines (CPGs) globally. However, the level of scientific evidence supporting ESMO...
5.
Stuart A, Ilic M, Simmons B, Sutherland W
Ecol Evol
. 2024 Apr;
14(4):e11237.
PMID: 38633526
Graphs in research articles can increase the comprehension of statistical data but may mislead readers if poorly designed. We propose a new plot type, the sea stack plot, which combines...
6.
Laniece Delaunay C, Martinez-Baz I, Seve N, Domegan L, Mazagatos C, Buda S, et al.
Euro Surveill
. 2024 Mar;
29(13).
PMID: 38551095
BackgroundScarce European data in early 2021 suggested lower vaccine effectiveness (VE) against SARS-CoV-2 Omicron lineages than previous variants.AimWe aimed to estimate primary series (PS) and first booster VE against symptomatic...
7.
Maurel M, Pozo F, Perez-Gimeno G, Buda S, Seve N, Oroszi B, et al.
Influenza Other Respir Viruses
. 2024 Jan;
18(1):e13243.
PMID: 38204584
Background: Influenza A(H3N2) viruses dominated early in the 2022-2023 influenza season in Europe, followed by higher circulation of influenza A(H1N1)pdm09 and B viruses. The VEBIS primary care network estimated the...
8.
Vilibic-cavlek T, Janev-Holcer N, Bogdanic M, Ferenc T, Vujica Ferenc M, Krcmar S, et al.
Life (Basel)
. 2023 Sep;
13(9).
PMID: 37763260
Different vector-borne pathogens are present or have (re-)emerged in Croatia. Flaviviruses tick-borne encephalitis (TBEV), West Nile (WNV), and Usutu (USUV) are widely distributed in continental regions, while Toscana virus (TOSV)...
9.
Kissling E, Pozo F, Martinez-Baz I, Buda S, Vilcu A, Domegan L, et al.
Influenza Other Respir Viruses
. 2023 Jan;
17(1):e13069.
PMID: 36702797
Background: In 2021-2022, influenza A viruses dominated in Europe. The I-MOVE primary care network conducted a multicentre test-negative study to measure influenza vaccine effectiveness (VE). Methods: Primary care practitioners collected...
10.
Vilibic-cavlek T, Zidovec-Lepej S, Ferenc T, Savic V, Nemeth-Blazic T, Vujica Ferenc M, et al.
Life (Basel)
. 2023 Jan;
13(1).
PMID: 36676173
Viral hepatitis is a significant cause of morbidity and mortality worldwide. In Croatia, hepatitis B virus (HBV) and hepatitis C virus (HCV) are widely distributed, especially in some high-risk groups...